Modulation of vaccine response by concomitant probiotic administration

British Journal of Clinical Pharmacology

Volumn 75, Issue 3, 2013, Pages 663-670

  Maidens, Catherine ^a   Childs, Caroline ^a   Przemska, Agnieszka ^a   Dayel, Iman Bin ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Antibody; Immune response; Immunomodulation; Probiotic; Vaccine

Indexed keywords

BB 12; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GALACTOSE OLIGOSACCHARIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 5; L CASEI 431; MEASLES MUMPS RUBELLA VACCINE; PROBIOTIC AGENT; ROTAVIRUS VACCINE; TETANUS TOXOID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CD4+ T LYMPHOCYTE; DIET SUPPLEMENTATION; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; ROTAVIRUS INFECTION; TREATMENT DURATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGE FACTORS; AGED; ANIMALS; HUMANS; INFANT; PROBIOTICS; VACCINATION; VACCINES;

EID: 84873460640     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04404.x     Document Type: Article

References (37)

1. Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15: 1428-1518.
2. Guandalini S. Probiotics for children with diarrhea: an update. J Clin Gastroenterol 2008; 42 (Suppl. 2): S53-57.
3. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-144.
4. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-338.
5. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: (Suppl.): 430S-436.
6. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med 2005; 257: 78-92.
7. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001; 322: 1327.
8. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2010; 29: 312-316.
9. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009; 124: e172-179.
10. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 2006; 24: 6670-6674.
11. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 2010; 103: 58-68.
12. Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents 2009; 34: 197e1-197e10.
13. Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, Samartín S, Sanderson IR, Van Loo J, Vas Dias FW, Watzl B. Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 2005; 94: 452-481.
14. MacDonald TT, Bell I. Probiotics and the immune response to vaccines. Proc Nutr Soc 2010; 69: 442-446.
15. Thomas CM, Versalovic J. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 2010; 1: 148-163.
16. Pang IK, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 2011; 245: 209-226.
17. GeurtsvanKessel CH, Willart MAM, van Rijt LS, Muskens F, Kool M, Baas C, Tielemans K, Bennet C, Clausen BE, Hoogsteden HC, Osterhaus ADME, Rimmelzwaan GF, Lambrecht BN. Clearance of influenza virus from the lung depends on migratory langerin+CD11b -but not plasmacytoid dendritic cells. J Exp Med 2008; 205: 1621-1634.
18. Stoeker L, Nordone S, Gunderson S, Zhang L, Kajikawa A, La Voy A, Miller M, Klaenhammer TR, Dean GA. Assessment of Lactobacillus gasseri as a candidate oral vaccine vector. Clin Vaccine Immunol 2011; 18: 1834-1844.
19. Tsai YT, Cheng PC, Liao JW, Pan TM. Effect of administration of Lactobacillus paracasei subsp paracasei NTU 101 on Peyer's patch-mediated mucosal immunity. Int Immunopharmacol 2010; 10: 791-798.
20. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13: 310-312.
21. Matsuda F, Chowdhury MI, Saha A, Asahara T, Nomoto K, Tarique AA, Ahmed T, Nishibuchi M, Cravioto A, Qadri F. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 2011; 29: 1855-1858.
22. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy - a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006; 17: 416-421.
23. Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen-and vaccine-specific immune responses. Clin Exp Allergy 2006; 36: 1227-1235.
24. West CE, Gothefors L, Granström M, Käyhty H, Hammarström ML, Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2008; 19: 53-60.
25. Soh SE, Ong DQ, Gerez I, Zhang X, Chollate P, Shek LP, Lee BW, Aw M. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010; 28: 2577-2579.
26. Youngster I, Kozer E, Lazarovitch Z, Broide E, Goldman M. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch Dis Child 2011; 96: 345-349.
27. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10: 55-63.
28. Fang H, Elina T, Heikki A, Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 2000; 29: 47-52.
29. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 2005; 44: 406-413.
30. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 2008; 53: 107-113.
31. Olivares M, Díaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonollá J, Navas M, Rodríguez JM, Xaus J. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 2007; 23: 254-260.
32. ® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr 2012; 107: 876-884.
33. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 2011; 65: 501-507.
34. Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 2007; 9: 1-17.
35. Bunout D, Barrera G, Hirsch S, Gattas V, de la Maza MP, Haschke F, Steenhout P, Klassen P, Hager C, Avendaño M, Petermann M, Muñoz C. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr 2004; 28: 348-354.
36. Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009; 27: 5677-5684.
37. Namba K, Hatano M, Yaeshima T, Takase M, Kunihiko S. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titre, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem 2010; 74: 939-945.